業績

{ 47件 }

Kono MR, Yasuda S, Kono MT, Atsumi T. Tocilizumab reduced production of systemic sclerosis-related autoantibodies and anti-cyclic citrullinated protein antibodies in two patients with overlapping systemic sclerosis and rheumatoid arthritis. Scand J Rheumatol. 2017: 8; 1-3. PMID 28480784
  • 2017
  • 膠原病グループ
  • 欧文論文/letter
Eric H Jego and O. Amengual “Current trends in medical English education and the Japan College of Rheumatology International School” Modern Rheumatology (PMID 28395582)
  • 2017
  • 膠原病グループ
  • 欧文論文/原著
Aki Kondo, Akinobu Nakamura, Jun Takeuchi, Hideaki Miyoshi, Tatsuya Atsumi. Insulin-induced distant-site lipoatrophy.Diabetes Care, in press (PMID:28396362).
  • 2017
  • 糖尿病・内分泌グループ
  • 欧文論文/症例報告
Aika Miya, Akinobu Nakamura, Hideaki Miyoshi, Kyu Yong Cho, So Nagai, Yoshio Kurihara, Shin Aoki, Masataka Taguri, Yasuo Terauchi, Tatsuya Atsumi. Satisfaction of switching to combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes receiving multiple daily insulin injection therapy: a randomized controlled trial. J Diabetes Investig, in press. (PMID:28296201)
  • 2017
  • 糖尿病・内分泌グループ
  • 欧文論文/原著
Nomoto H, Miyoshi H, Nakamura A, Atsumi T, Manda N, Kurihara Y, and Aoki S. Impact of incretin related-agents on endothelial cell function. Clinical Trials in Degenerative Diseases, In press
  • 2017
  • 糖尿病・内分泌グループ
  • 欧文論文/総説

Eri Sugawara, Masaru Kato, Takahiro Sato, Kenta Takahashi, Michihiro Kono, Ryo Hisada, Michihito Kono, Kenji Oku, Toshiyuki Bohgaki, Shinsuke Yasuda, Ichizo Tsujino, Shinya Tanaka,Tatsuya Atsumi.

Diversity of Borderline Pulmonary Arterial Pressure Associated with Systemic Sclerosis: 3 Case series. Mod Rheumatol Case Rep., 08 Nov 2016 

  • 2017
  • 膠原病グループ
  • 欧文論文/症例報告

Nomoto H, Misyoshi H, Nakamura A, Atsumi T. Do DPP-4 inhibitors improve endothelial cell function?. Current Trends in Cardiology, in Press 

  • 2017
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Nomoto H, Kimachi K, Miyoshi H, Kameda H, Cho KY, Nakamura H, Nagai S, Kondo T, Atsumi T. Effects of vildagliptin 50 mg twice daily vs. sitagliptin 50mg once daily on blood glucose fluctuations evaluated by long-term self-monitoring of blood glucose. Endocrine Journal. In press (PMID: 28260702)

  • 2017
  • 糖尿病・内分泌グループ
  • 欧文論文/原著
Yasuda S, Ohmura K, Kanazawa H, Kurita T, Kon Y, Ishii T, Fujieda Y, Jodo S, Tanimura K, Minami M, Izumiyama T, Matsumoto T, Amasaki Y, Suzuki Y, Kasahara H, Yamauchi N, Kato M, Kamishima T, Tsutsumi A, Takemori H, Koike T, Atsumi T.  Maintenance Treatment using Abatacept with Dose Reduction after Achievement of Low Disease Activity in Patients with Rheumatoid Arthritis (MATADOR) – A prospective, multicenter, single arm pilot clinical trial. Mod Rheumatol. (PMID 28150514)
  • 2017
  • 膠原病グループ
  • 欧文論文/原著
Atsumi T, Tanaka Y, Yamamoto K, Takeuchi T, Yamanaka H, Ishiguro N, Eguchi K, Watanabe A, Origasa H, Yasuda S, Yamanishi Y, Kita Y, Matsubara T, Iwamoto M, Shoji T, Togo O, Okada T, van der Heijde D, Miyasaka N, Koike T.  Clinical benefit of 1-year certolizumab pegol (CZP) add-on therapy to methotrexate treatment in patients with early rheumatoid arthritis was observed following CZP discontinuation: 2-year results of the C-OPERA study, a phase III randomised trial.  Ann Rheum Dis.(PMID 28153828)
  • 2017
  • 膠原病グループ
  • 欧文論文/原著